BioCentury
ARTICLE | Company News

Isis other research news

October 29, 2001 8:00 AM UTC

ISIP's Ibis Therapeutics division received an additional 2-year DARPA grant of up to $7.1 million to develop a sensor to detect infectious disease agents used in biological attacks. The company receiv...